Tandem Diabetes Care
TNDM
265 hedge funds and large institutions have $2.98B invested in Tandem Diabetes Care in 2019 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 15 closing their positions.
453% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 15
71% more funds holding in top 10
Funds holding in top 10: 7 → 12 (+5)
64% more capital invested
Capital invested by funds: $1.81B → $2.98B (+$1.16B)
56% more call options, than puts
Call options by funds: $84.5M | Put options by funds: $54M
33% more funds holding
Funds holding: 200 → 265 (+65)
1% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 81
1.94% less ownership
Funds ownership: 83.13% → 81.19% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$75.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.4M |
| 3 |
D.E. Shaw & Co
New York
|
+$25.4M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$22M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$56.9M |
| 2 |
Renaissance Technologies
New York
|
-$33.5M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$28.5M |
| 5 |
DM
Deerfield Management
New York
|
-$27.2M |
TNDM Hedge Fund Activity: Q1 2019 in Review
265 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2019, worth a combined $2.98B — up 64% from $1.81B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new TNDM positions and 15 closed out — a net gain of 68 holders — while 80 added to existing stakes and 81 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $75.4M. The largest seller was Point72 Asset Management, cutting an estimated $56.9M.
- 265 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2019, up from 200 in Q4 2018.
- Funds reported $2.98B of Tandem Diabetes Care stock for Q1 2019, up 64% quarter-over-quarter.
- 83 funds opened new Tandem Diabetes Care positions in Q1 2019 and 15 closed out, a net change of +68 holders.
- The largest Tandem Diabetes Care buyer in Q1 2019 was Wellington Management Group, an estimated $75.4M added.
- The largest Tandem Diabetes Care seller in Q1 2019 was Point72 Asset Management, an estimated $56.9M sold.
Based on aggregated 13F filings for Q1 2019.